Taiho Pharmaceutical Co., Ltd.Usage: INQOVI treats adult patients with myelodysplastic syndromes (MDS) — including refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, and CMML — across intermediate-1, intermediate-2, and high-risk IPSS groups, both previously treated and untreated.